Abstract: A roller member includes a core member; a substantially round-cylindrical elastic member through which the core member extends and having chamfered portions, the chamfered portions each provided at two respective ends of the elastic member and having a surface roughness of about 50 ?m or less; and a coating film provided over an outer peripheral surface of the elastic member and at least a part of each of the chamfered portions.

Abstract: A tubular body for an image forming apparatus is formed by subjecting a tubular member containing a thermoplastic resin to thermal processing. The thermal processing is performed so that at least one edge of the tubular member is thermally melted and then cured in at least a portion of the edge in a peripheral direction.

Abstract: A tubular body for an image forming apparatus is formed by subjecting a tubular member containing a thermoplastic resin to thermal processing. The thermal processing is performed so that at least one edge of the tubular member is thermally melted and then cured in at least a portion of the edge in a peripheral direction.

Abstract: A tubular member includes a resin layer containing a thermoplastic resin and a conductive material, and the resin layer forming a sea part in which the thermoplastic resin becomes a matrix phase, wherein an area ratio of the sea part to a portion in a range of 5 ?m respectively to a front surface portion side and a rear surface portion side with a central portion of the resin layer in a thickness direction as a center is greater by 3% to 15% than a greater area ratio between an area ratio of the sea part to a portion in a range of 10 ?m from a front surface portion of the resin layer in the thickness direction and an area ratio of the sea part to a portion in a range of 10 ?m from a rear surface portion in the thickness direction.

Abstract: A tubular member includes a resin layer containing a thermoplastic resin and a conductive material, and the resin layer forming a sea part in which the thermoplastic resin becomes a matrix phase, wherein an area ratio of the sea part to a portion in a range of 5 ?m respectively to a front surface portion side and a rear surface portion side with a central portion of the resin layer in a thickness direction as a center is greater by 3% to 15% than a greater area ratio between an area ratio of the sea part to a portion in a range of 10 ?m from a front surface portion of the resin layer in the thickness direction and an area ratio of the sea part to a portion in a range of 10 ?m from a rear surface portion in the thickness direction.

Abstract: A fixing device includes a heating member that heats a toner image on a recording medium and includes a rotatable belt member, a heat source, a pressing member, a sliding sheet, and a pressure-applying member. The pressing member presses the belt member against the pressure-applying member. A surface of the pressing member that opposes the belt member includes a flat portion or a recessed portion having a radius of curvature of approximately 100 mm or more. The sliding sheet is disposed between the belt member and the pressing member and includes a sliding layer containing cross-linked polytetrafluoroethylene, the content of which in resin contained in the layer is approximately 25 mass % or more and approximately 75 mass % or less. The pressure-applying member presses the recording medium against the belt member and rotates to transport the recording medium while nipping it between itself and the belt member.

Abstract: An image processing apparatus that comprises a plurality of read out rows in an imaging unit of the apparatus. The imaging region comprises of a plurality of pixels which are equipped with color filters of the red, blue and green type. The apparatus comprises a controller configured to set a frame rate for a first row scanning unit and a second frame rate for a second row scanning unit. The apparatus is further configured to perform image interpolation and perform the auto focus, auto exposure, auto black white or the like functions and display an image with a high resolution on a display unit.

Abstract: A fixing device includes a heating member that heats a toner image on a recording medium and includes a rotatable belt member, a heat source, a pressing member, a sliding sheet, and a pressure-applying member. The pressing member presses the belt member against the pressure-applying member. A surface of the pressing member that opposes the belt member includes a flat portion or a recessed portion having a radius of curvature of approximately 100 mm or more. The sliding sheet is disposed between the belt member and the pressing member and includes a sliding layer containing cross-linked polytetrafluoroethylene, the content of which in resin contained in the layer is approximately 25 mass % or more and approximately 75 mass % or less. The pressure-applying member presses the recording medium against the belt member and rotates to transport the recording medium while nipping it between itself and the belt member.

Abstract: An image fixing device includes a first rotating body, a second rotating body, a pressing member, a sheet member, and a lubricant. The second rotating body is disposed in contact with an outer surface of the first rotating body. The pressing member is disposed within the second rotating body and presses the second rotating body toward the first rotating body from an inner surface of the second rotating body. The sheet member is disposed between the second rotating body and the pressing member and has a slide layer containing cross-linked polytetrafluoroethylene resin. The lubricant is interposed between the second rotating body and the sheet member and contains amino-modified silicone oil and terminal-modified perfluoropolyether.

Abstract: Provided is a tubular body manufacturing method including preparing a resin composition containing a crystalline thermoplastic resin and molding the tubular body, using an extrusion molding machine that includes a cylindrical portion and a transport member which has a shaft member and a protrusion and is divided into a supply portion, a compressing portion and a measuring portion, by melting, kneading and transporting the resin composition through heating of the heat source and rotation of the transport member, and then extruding the molten resin composition, in which, when ?Tm (° C.) is a difference between a crystalline melt finish temperature and a crystalline melt start temperature of the crystalline thermoplastic resin, D (mm) is a diameter of the transport member, and Lc (mm) is a length of the compressing portion of the transport member, a relationship of following Expression (1) is satisfied: (?Tm/10)?3<Lc/D<(?Tm/10)+1.

Abstract: A medical container comprising a body for containing a medicament, the body of the medical container being formed of a multilayered film comprising (i) a layer formed of a linear polyolefin and (ii) a layer formed of a cyclic polyolefin adjacent to the layer (i), and the layer (i) formed of the linear polyolefin satisfying the following conditions (a) and/or (b): Condition (a): an amount of a liquid component, which remains after Soxhlet's extraction with organic solvents followed by evaporation of the solvents, is 0.2% by weight or less, and Condition (b): a branching degree of a component, which remains after Soxhlet's extraction with n-hexane followed by evaporation of n-hexane, is 50 or less per 1,000 carbon atoms.

Abstract: The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39 in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

Abstract: A drug container with no need to peel a gas-barrier film or with no need to contain a desiccant, an oxygen absorbent or the like, in which the contents therein can be seen by the naked eyes. The container (10) comprises a front sheet (20) and a rear sheet (22), the front sheet (20) and the rear sheet (22) being fusion-bonded each other so as to form a space (14) therebetween, wherein the front sheet is constituted of a multilayered film having a linear-polyolefin layer as the outermost layer, wherein the rear sheet is constituted of a multilayered film having at least one selected from a group consisting of a metal foil, a vapor-deposited metal layer and a vapor-deposited inorganic layer, and wherein a transparent covering sheet (24) comprising a film having a vapor-deposited metal oxide layer is fusion-bonded to the front sheet so that the entire outer surface of at least a part of the front sheet which forms the space can be covered with the transparent covering sheet (24).

Abstract: The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

Abstract: Embodiments of a gas distribution plate for distributing gas in a processing chamber for large area substrates are provided. The embodiments describe a gas distribution plate assembly for a plasma processing chamber having a cover plate comprises a diffuser plate having an upstream side, a downstream side facing a processing region, and a plurality of gas passages formed through the diffuser plate, and a baffle plate, placed between the cover plate of the process chamber and the diffuser plate, having a plurality of holes extending from the upper surface to the lower surface of the baffle plate, wherein the plurality of holes have at least two sizes. The small pinholes of the baffle plate are used to allow sufficient pass-through of gas mixture, while the large holes of the baffle plate are used to improve the process uniformity across the substrate.

Abstract: A medical container comprising a body for containing a medicament, the body of the medical container being formed of a multilayered film comprising (i) a layer formed of a linear polyolefin and (ii) a layer formed of a cyclic polyolefin adjacent to the layer (i), and the layer (i) formed of the linear polyolefin satisfying the following conditions (a) and/or (b): Condition (a): an amount of a liquid component, which remains after Soxhlet's extraction with organic solvents followed by evaporation of the solvents, is 0.2% by weight or less, and Condition (b): a branching degree of a component, which remains after Soxhlet's extraction with n-hexane followed by evaporation of n-hexane, is 50 or less per 1,000 carbon atoms.

Abstract: The present invention is to provide a novel phosphodiesterase and a gene thereof, specifically, Type 11 phosphodiesterase (PDE11) and a gene thereof, more specifically, a phosphodiesterase selected from (A) a protein having an amino acid sequenced shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39, and (B) a protein having an amino acid sequence shown by SEQ.ID.NO: 2, SEQ.ID.NO: 4, SEQ.ID.NO: 6 or SEQ.ID.NO: 39 in which one or several amino acids are deleted, substituted or added, and having an activity of hydrolyzing a cyclic nucleotide, and a gene thereof, and a method of characterizing, identifying and selecting a phosphodiesterase inhibitor by using the same.

Abstract: 1. A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ?CH— or ?N—, Y is —NH—, —NR4—, —S—, —O—, —CH?N—, —N?CH—, —N?N—, —CH?CH—, etc., R1 is a lower alkoxy group, an amino group, a heterocyclic ring containing N atom(s), or a hydroxy group substituted by a heterocyclic ring containing N atom(s) (each of which is optionally substituted), R2 is a lower alkylamino group which is optionally substituted by an aryl group, a lower alkoxy group which is optionally substituted by an aryl group, a lower alkoxy group substituted by an aromatic heterocyclic ring containing N atom(s), R3 is an aryl group, a heterocyclic ring containing N atom(s), a lower alkyl group, a lower alkoxy group, a cyclo lower alkoxy group, a hydroxy group substituted by a heterocyclic ring containing N atom(s), or an amino group (each of which is optionally substituted), and R3 and a substituent in Y may be combined to form a lactone ring.

Abstract: 1. A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ?CH— or ?N—, Y is —NH—, —NR4—, —S—, —O—, —CH?N—, —N?CH—, —N?N—, —CH?CH—, etc., R1 is a lower alkoxy group, an amino group, a heterocyclic ring containing N atom(s), or a hydroxy group substituted by a heterocyclic ring containing N atom(s) (each of which is optionally substituted), R2 is a lower alkylamino group which is optionally substituted by an aryl group, a lower alkoxy group which is optionally substituted by an aryl group, a lower alkoxy group substituted by an aromatic heterocyclic ring containing N atom(s), R3 is an aryl group, a heterocyclic ring containing N atom(s), a lower alkyl group, a lower alkoxy group, a cyclo lower alkoxy group, a hydroxy group substituted by a heterocyclic ring containing N atom(s), or an amino group (each of which is optionally substituted), and R3 and a substituent in Y may be combined to form a lactone ring.

Abstract: A medicine bag, which includes a bag body having a medicine storage chamber that stores a medicine in such a way that the medicine is visually confirmed through a light-transmission portion provided in at least one part of the bag body, the bag body having a weak seal portion that divides the medicine storage chamber into a plurality of division spaces, and the sealing of the weak seal portion adjacent to a specific division space being removed by increasing the internal pressure of that division space, including: a cover sheet which is peelably attached to the bag body; and a requisitely-used portion which is used in the process shortly before the medicine is administered, in which the cover sheet includes: a light-shielding portion which shields from the light the medicine stored in at least one division space by covering a predetermined part of the light-transmission portion; and a continuously-formed portion which is continuously formed in the light-shielding portion and is placed so that the requisitely-